Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry

First Page		Document Content
Food and Drug Administration Pharmaceutical industry Pharmaceuticals policy Food law Abbreviated New Drug Application New drug application Federal Food Drug and Cosmetic Act Generic drug Approved Drug Products with Therapeutic Equivalence Evaluations Center for Drug Evaluation and Research Drug Master File		Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 94,11 KB Share Document on Facebook

	Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace DocID: 1uvYN - View Document
	Emergency Use: means the use of a test article on a human subject in a life-threatening situation in DocID: 1riMu - View Document
	United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. Senate DocID: 1riEa - View Document
	Microsoft Word - FINAL 10K2014-Cover Page final to print DocID: 1r76P - View Document
	Clark Transfer, Inc. Owner-Operator Application IMPORTANT NOTICE REGARDING BACKGROUND REPORTS DocID: 1qZGZ - View Document